Defiance Daily Target 2X Long NVO ETF (NVOX)

Assets	$40.08M
Expense Ratio	1.30%
PE Ratio	n/a
Shares Out	2.69M
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	467,113
Open	16.02
Previous Close	15.78
Day's Range	15.72 - 16.30
52-Week Low	9.23
52-Week High	54.76
Beta	n/a
Holdings	12
Inception Date	Dec 2, 2024

About NVOX

Fund Home Page

The Defiance Daily Target 2X Long NVO ETF (NVOX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to deliver 2x leveraged exposure to the daily share price movement of NOVO Nordisk A/S - ADR (NVO), less fees and expenses, through derivatives like swap agreements. NVOX was launched on Dec 2, 2024 and is issued by Defiance.

• Asset Class: Equity
• Category: Trading--Leveraged Equity
• Stock Exchange: NYSEARCA
• Ticker Symbol: NVOX
• ETF Provider: Defiance

Top 10 Holdings

269.18% of assets

Name	Symbol	Weight
NOVO-NORDISK SWAP MS	n/a	57.07%
NOVO-NORDISK SWAP NBC-L	n/a	28.39%
NOVO-NORDISK SWAP MAREX	n/a	25.21%
NOVO-NORDISK A/S-SPONS ADR NOMURA	n/a	24.99%
US DOLLARS	n/a	24.98%
OTHER ASSETS AND LIABILITIES	n/a	24.47%
NOVO-NORDISK SWAP CLEARSTREET	n/a	22.39%
NOVO-NORDISK INC SWAP CANTOR	n/a	22.22%
NOVO-NORDISK SWAP BMO-L	n/a	21.58%
United States Treasury Bills 0%	B.0 06.25.26	17.88%

Performance

NVOX had a total return of -70.73% in the past year, including dividends. Since the fund's inception, the average annual return has been -77.96%.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP. Several fund data points are also provided by Finnhub.

Last checked:

Jun 26, 2026

Data Sources Report a data error